Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition. Advances in biotechnology and genomics have given scientists new hope that biomarkers can be used to improve cancer screening and detection, to improve the drug development process, and to enhance the effectiveness and safety of cancer care by allowing physicians to tailor treatment for individual patients—an approach known as personalized medicine. However, progress overall has been slow, despite considerable effort and investment, and there are still many challenges and obstacles to overcome before this paradigm shift in oncology can become a reality.
"synopsis" may belong to another edition of this title.
Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors
"About this title" may belong to another edition of this title.
Seller: WeBuyBooks, Rossendale, LANCS, United Kingdom
Condition: Like New. Most items will be dispatched the same or the next working day. An apparently unread copy in perfect condition. Dust cover is intact with no nicks or tears. Spine has no signs of creasing. Pages are clean and not marred by notes or folds of any kind. Seller Inventory # rev8254904639
Quantity: 1 available
Seller: Les-Feuillets-du-Vidourle, SAUVE, France
Broché. Condition: D'occasion - Très bon état. Livre en très bon état. A20. Seller Inventory # HO-BRQF-HSL1
Seller: BennettBooksLtd, Los Angeles, CA, U.S.A.
Condition: New. New. In shrink wrap. Looks like an interesting title! 0.85. Seller Inventory # Q-030910386X